Key result
Baroreflex activation therapy (BAT) shows promising results in reducing blood pressure and heart rate for drug-resistant hypertension, with unilateral stimulation appearing as effective as bilateral.
Why the study?
Does carotid baroreflex activation therapy reduce blood pressure in patients with drug-resistant hypertension?
Population
Patients with drug-resistant hypertension
Design
Review
Authors
Loading...
May support unilateral BAT in resistant hypertension; leaves open need for RCTs before clinical adoption.
Does carotid baroreflex activation therapy reduce blood pressure in patients with drug-resistant hypertension?
Second-generation unilateral baroreflex activation therapy shows promise in reducing blood pressure and heart rate in drug-resistant hypertension, with potential future applications in systolic heart failure.
Alnima et al. (2012) conducted a review in Drug-resistant hypertension. Baroreflex activation therapy (BAT) was evaluated. Baroreflex activation therapy (BAT) shows promising results in reducing blood pressure and heart rate for drug-resistant hypertension, with unilateral stimulation appearing as effective as bilateral.